MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-19-2025
Country |
 USA |
IPO year |
2015 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
4.66 M |
Market Cap[1] |
$ 1.54 M |
EBITDA (LTM) |
$ -10.5 M |
P/E (LTM) |
- |
P/S (LTM) |
0.32 |
EPS (LTM) |
1.68 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Agilent Technologies
A
|
$ 114.84 | -0.55 % | $ 34.9 B | NYSE,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
CareDx, Inc
CDNA
|
$ 17.82 | -2.68 % | $ 950 M | Nasdaq Global Market,SPB | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 16.3 | 0.62 % | $ 175 M | Nasdaq Global Market |  China |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
|
Biodesix
BDSX
|
$ 15.36 | 1.92 % | $ 1.99 B | Nasdaq Global Market | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Co-Diagnostics
CODX
|
$ 4.4 | 101.83 % | $ 5.85 M | Nasdaq Capital Market | USA |
 |
Anixa Biosciences
ANIX
|
$ 2.59 | 1.57 % | $ 84.1 K | Nasdaq Capital Market | USA |
 |
Biomerica
BMRA
|
$ 2.17 | - | $ 4.98 M | Nasdaq Capital Market | USA |
 |
BioNano Genomics
BNGO
|
$ 1.15 | -4.17 % | $ 6.26 M | Nasdaq Capital Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 168.22 | -3.26 % | $ 8.34 B | NYSE,SPB | USA |
 |
Castle Biosciences
CSTL
|
$ 24.73 | -0.44 % | $ 687 M | Nasdaq Global Market,SPB | USA |
 |
Danaher Corporation
DHR
|
$ 192.12 | 0.52 % | $ 137 B | NYSE,SPB | USA |
 |
Celcuity
CELC
|
$ 114.22 | 1.41 % | $ 5.34 B | Nasdaq Global Select Market | USA |
 |
DexCom
DXCM
|
$ 63.21 | 1.59 % | $ 24.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 16.42 | -2.38 % | $ 496 M | Nasdaq Global Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Guardant Health
GH
|
$ 89.66 | -4.44 % | $ 11.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 198.96 | 0.91 % | $ 22.1 B | NYSE,SPB | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
ICON Public Limited Company
ICLR
|
$ 109.62 | -4.0 % | $ 9.04 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Illumina
ILMN
|
$ 127.74 | 0.28 % | $ 20.3 B | Nasdaq Global Select Market,SPB | USA |
 |
IQVIA Holdings
IQV
|
$ 170.72 | -1.47 % | $ 29.3 B | NYSE,SPB | USA |
 |
Interpace Biosciences
IDXG
|
$ 1.97 | 0.63 % | $ 8.72 M | Nasdaq Global Select Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 274.46 | 0.27 % | $ 22.8 B | NYSE,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 75.89 | -0.28 % | $ 5.12 B | Nasdaq Global Select Market,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 496.0 | -0.47 % | $ 14.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 266.63 | 0.53 % | $ 26.1 B | NYSE,SPB |  Schweiz |
 |
Myriad Genetics
MYGN
|
$ 4.67 | -1.68 % | $ 432 M | Nasdaq Global Select Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 4.74 | 1.07 % | $ 3.73 M | Nasdaq Global Select Market | USA |
 |
NeoGenomics
NEO
|
$ 8.02 | 0.25 % | $ 1.03 B | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 9.56 | 1.59 % | $ 2.07 B | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 17.33 | 0.99 % | $ 388 M | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.